Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 1997-2001, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wehmann, R. E.
Right arrow Articles by Nisula, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wehmann, R. E.
Right arrow Articles by Nisula, B. C.

Clinical Chemistry, Vol 27, 1997-2001, Copyright © 1981 by American Association for Clinical Chemistry

Convenient radioimmunoassay for urinary human choriogonadotropin without interference by urinary human lutropin

RE Wehmann, SM Harman, S Birken, RE Canfield and BC Nisula

We have devised a radioimmunoassay (RIA) for human choriogonadotropin (hCG) in first morning-voided urine specimens. Concanavalin A, a lectin, is used to extract and concentrate the hCG from urine. A high- affinity antiserum is used, directed to the hCG beta carboxy-terminal peptide, a unique immunological determinant not shared by the beta subunit of human lutropin. This ensures that urinary human lutropin- related molecules, which interfere with RIAs involving antisera to the intact hCG beta subunit, will not cross react in this assay. A concentrations of hCG as low as 0.4 microgram/L can be detected in the first morning-voided urine. The effective sensitivity of this assay for the unequivocal detection of hCG production is somewhat better than that achieved with the serum hCG RIA involving antisera to the hCG beta subunit. The improved specificity and sensitivity of this assay, and the greater convenience of collecting samples of urine rather than blood, are clinical useful advantages of this approach to assessing hCG production in humans.


The following articles in journals at HighWire Press have cited this article:


Home page
 Biol. Reprod.Home page
D. D. Baird, C. R. Weinberg, D. R. McConnaughey, and A. J. Wilcox
Rescue of the Corpus Luteum in Human Pregnancy
Biol Reprod, February 1, 2003; 68(2): 448 - 456.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.